HCA Healthcare (NYSE:HCA) Price Target Raised to $468.00

HCA Healthcare (NYSE:HCA) had its price objective boosted by Wells Fargo & Company from $381.00 to $468.00 in a research note issued to investors on Monday,Benzinga reports. They currently have an equal weight rating on the stock.

Other equities analysts also recently issued reports about the stock. JPMorgan Chase & Co. lowered their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a report on Thursday, August 20th. Weiss Ratings upgraded shares of HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Leerink Partners restated an “outperform” rating and set a $492.00 price objective on shares of HCA Healthcare in a research note on Friday, September 18th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a report on Monday, July 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $480.13.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $510.31 on Monday. The stock has a 50 day moving average price of $440.51 and a 200 day moving average price of $444.90. The stock has a market capitalization of $106.60 billion, a PE ratio of 15.44, a price-to-earnings-growth ratio of 1.55 and a beta of 1.11. HCA Healthcare has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, topping the consensus estimate of $6.65 by $0.57. The firm had revenue of $19.85 billion for the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business’s quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.96 EPS. As a group, research analysts forecast that HCA Healthcare will post 30.15 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare’s dividend payout ratio is 10.34%.

Institutional Trading of HCA Healthcare

A number of hedge funds have recently modified their holdings of HCA. Lido Advisors LLC boosted its stake in shares of HCA Healthcare by 91.3% in the 3rd quarter. Lido Advisors LLC now owns 10,907 shares of the company’s stock valued at $4,655,000 after purchasing an additional 5,206 shares in the last quarter. Keybank National Association OH increased its position in HCA Healthcare by 6.8% during the 3rd quarter. Keybank National Association OH now owns 2,732 shares of the company’s stock worth $1,166,000 after purchasing an additional 173 shares in the last quarter. Cornerstone Wealth Management LLC acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $244,000. Narwhal Capital Management lifted its stake in HCA Healthcare by 10.4% in the 3rd quarter. Narwhal Capital Management now owns 7,521 shares of the company’s stock valued at $3,210,000 after purchasing an additional 708 shares during the last quarter. Finally, D Orazio & Associates Inc. boosted its position in HCA Healthcare by 13.0% in the third quarter. D Orazio & Associates Inc. now owns 652 shares of the company’s stock valued at $278,000 after buying an additional 75 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Hospitals and health insurers rallied after Democrats’ midterm gains, a sector-wide move that likely helped lift HCA. The coverage does not specify which policy changes investors expect. Article: Health insurers, hospitals rally after sweeping midterm win for Democrats
• Positive Sentiment: HCA’s quarterly results beat expectations: adjusted earnings were $7.22 per share versus a $6.65 consensus estimate, and revenue was $19.85 billion versus $19.33 billion. Revenue grew 3.6% year over year. Article: Why HCA Healthcare is a top growth stock for the long term
• Positive Sentiment: Wells Fargo raised its price target on HCA, while Truist reaffirmed its Buy rating and lifted its target to $510 from $495. These moves signal continued analyst support. Article: HCA Healthcare stock gets price target boost from Wells Fargo Article: Truist reaffirms Buy rating
• Positive Sentiment: HCA Houston Healthcare Northwest introduced next-generation robotic-assisted surgical technology, which may strengthen its service offering and competitive position. Article: HCA Houston Healthcare Northwest introduces robotic-assisted surgical technology
• Neutral Sentiment: HCA is planning a $300 million hospital in Cape Coral, with $31 million in city incentives. The project supports expansion, though its investment and execution costs may take time to translate into returns. Article: Cape Coral lands $300 million HCA hospital
• Neutral Sentiment: HCA launched a senior-notes offering; the article listing does not provide details on terms or intended use of proceeds, so the effect on leverage is unclear. Article: HCA Healthcare launches senior notes offering
• Negative Sentiment: Uninsured-patient costs reportedly shifted by $400 million in HCA’s third-quarter payer mix, a potential headwind to profitability. Article: HCA Q3 revenue by payer as uninsured shift costs $400M
• Negative Sentiment: Reports of data breaches involving HCA raise potential privacy, regulatory, and reputational concerns; the article listing does not specify the impact. Article: Data breaches announced by HCA Healthcare
• Negative Sentiment: A law firm announced an investigation into claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but it can create legal and reputational uncertainty. Article: Pomerantz investigates claims on behalf of HCA investors

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.